Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on July 30, 2019, to report its financial results for the second quarter ended June 30, 2019. The company issued a press release detailing these results, which is included as an exhibit to the filing. Gilead presented its financial information using both U.S. Generally Accepted Accounting Principles (GAAP) and non-GAAP measures, with management highlighting the utility of non-GAAP information for investors to supplement their understanding of the company's operating performance. This non-GAAP information is used internally for operational planning and budgeting, and a reconciliation to GAAP figures is provided in the press release. While the filing itself is procedural, the core of the announcement lies within the accompanying press release (Exhibit 99.1). Investors should refer to this press release for specific details on revenue, earnings per share, and any segment-specific performance, as well as management's commentary on the quarter's results and future outlook. The use of non-GAAP measures suggests management's focus on underlying operational trends, but it's crucial for investors to review the reconciliation to fully grasp the impact of any adjustments on reported figures.
Key Highlights
- 1Gilead Sciences announced its second-quarter 2019 financial results via a press release filed on July 30, 2019.
- 2The company provided financial data on both a GAAP and non-GAAP basis.
- 3Management believes non-GAAP financial measures offer valuable insights for investors, complementing GAAP reporting.
- 4Non-GAAP figures are utilized internally for operating, budgeting, and financial planning.
- 5A reconciliation between GAAP and non-GAAP financial information is available within the press release (Exhibit 99.1).
- 6Investors are directed to the press release for detailed financial performance and operational commentary.